Albert “Skip” Rizzo | VR Therapy & Mental Health | Lifetime Achievement in Virtual Reality Award

Prof. Albert “Skip” Rizzo | VR Therapy & Mental Health | Lifetime Achievement in Virtual Reality Award

USC-Institute for Creative Technologies | United States

Albert “Skip” Rizzo, Ph.D., is an internationally recognized clinical psychologist and neuropsychologist who founded one of the world’s first Clinical Virtual Reality laboratories at USC in 1995 and currently serves as Director of Medical VR at the USC Institute for Creative Technologies, where he has spent three decades designing, developing, and evaluating over 60 VR and Virtual Human systems for clinical diagnosis, treatment, and research across domains such as PTSD, anxiety, depression, autism, ADHD, stroke, traumatic brain injury, cerebral palsy, and other health conditions; best known for his groundbreaking BRAVEMIND PTSD therapy used with veterans and trauma survivors, he has collaborated extensively with computer scientists, engineers, artists, and medical leaders to advance the field, earning widespread recognition including being named one of Polygon’s top 25 VR innovators, Ozy’s “Godfather of Virtual Reality,” recipient of the 2018 Michael Dell “Engine of Human Progress” award, the ISTSS Trauma Innovation Award, the International Society on Virtual Rehabilitation Distinguished Service Award, the Best Paper Award for his VR ADHD classroom study involving 700 children, and the 2023 IEEE VR Lifetime Achievement Award; his team also secured second place and $1M funding in the VA Mission Daybreak competition for the Battle Buddy suicide-prevention system, while his career research portfolio exceeds $60M in funding—$30M specifically in Virtual Humans—with major grants from the Department of Defense, DARPA, VA, Army Research Lab, and leading industry partners including HP, Nvidia, Google, Dell, Intel, Samsung, HTC/Valve, AMD, Magic Leap, and many others; with more than 350 peer-reviewed publications, 31 chapters, 10 books, over 1000 professional presentations, 41 awards, and over 1000 media appearances, Dr. Rizzo’s influential body of work continues to shape and expand the global impact of clinical VR in healthcare and rehabilitation.

Profiles:  Orcid | Google Scholar

Featured Publications

Rizzo, A. S. (2025). Relationships between parent ratings of attention-deficit/hyperactivity disorder behaviors and the Virtual Reality Attention Tracker in school-aged children: Cross-sectional study. Journal of Medical Internet Research.

Rizzo, A. S. (2025). Virtual reality exposure for treating PTSD due to military sexual trauma. Journal of Clinical Psychology.

Rizzo, A. S. (2025). Expert consensus best practices for the safe, ethical, and effective design and implementation of artificially intelligent conversational agent (i.e., chatbot/virtual human) systems in health care applications. Journal of Medical Extended Reality.

Rizzo, A. S. (2024). Reporting guidelines for the early-phase clinical evaluation of applications using extended reality (RATE-XR): Qualitative study guideline. Journal of Medical Internet Research.

Rizzo, A. S. (2024). Advances in the use of virtual reality to treat mental health conditions. Nature Reviews Psychology.

Rizzo, A. S. (2024). Reporting guidelines for the early-phase clinical evaluation of applications using extended reality (RATE-XR): Qualitative study guideline (Preprint). JMIR Preprints.

Rizzo, A. S. (2023). Reporting the early-stage clinical evaluation of virtual-reality-based intervention trials: RATE-VR. Nature Medicine.

Rizzo, A. S. (2022). Enhancing exposure therapy for posttraumatic stress disorder: A randomized clinical trial of virtual reality and imaginal exposure with a cognitive enhancer. Translational Psychiatry.

Daniel Daneshvar | VR in Healthcare | Global Impact Award in Virtual Reality

Dr. Daniel Daneshvar | VR in Healthcare | Global Impact Award in Virtual Reality 

 

Harvard Medical School | United States

Daniel Daneshvar, MD, PhD, is an Assistant Professor in the Department of Physical Medicine and Rehabilitation at Harvard Medical School, where he has dedicated his clinical, research, educational, and community outreach efforts to improving care for individuals following traumatic brain injury (TBI), with a special focus on repetitive TBI (rTBI). He serves as Chief of Brain Injury Rehabilitation at Spaulding Rehabilitation and co-Chair of Sports Concussion at Mass General Brigham, providing care for patients with acute and long-term sequelae of TBI while supervising medical students, residents, fellows, and research trainees. Dr. Daneshvar’s work has advanced clinical understanding and diagnostic approaches to TBI, including leading the identification of a novel concussion sign—the spontaneous headshake after a kinematic event (SHAAKE)—now implemented on the sidelines by professional sports organizations including the National Football League and the UK’s Professional Footballers’ Association. He has contributed to national policy and standards through consensus work with the NFL Chief Medical Officer and as a panelist for the Brain Trauma Foundation and Military Traumatic Brain Injury Initiative. To enhance clinical management of rTBI, he developed a retrospective clinical assessment tool for informants of brain donors, now used across multiple North American centers, and created the first positional exposure matrix (PEM) to quantify head impact exposure, which has shaped research on chronic traumatic encephalopathy (CTE) and inspired CTE prevention protocols. His scholarship, including lead or senior author publications in JAMA, Acta Neuropathologica, and Nature Communications, has clarified the clinical and neuropathologic features of CTE, contributed to diagnostic criteria, and influenced the NIH’s 2023 acknowledgment of a causal link between rTBI and CTE. Dr. Daneshvar directs a research portfolio exceeding $2.7 million funded by philanthropy, NINDS, and the NFL Players Association, and serves as Senior Editor for Physical Medicine and Rehabilitation and Associate Editor for Frontiers in Neurology. A committed educator, he received Spaulding’s Distinguished Research Mentor Award and Teacher of the Year Award, established a resident research track, and supported over 35 resident publications in the past year. Committed to public health, he founded Team Up Against Concussions and now directs concussion education initiatives at TeachAids, whose CrashCourse program has reached over 500,000 athletes. His outreach includes more than 200 media interviews to advance public understanding of TBI. Through these integrated efforts, Dr. Daneshvar aims to elevate standards of TBI care, prevention, education, and research.

Profile: Orcid

Featured Publications

Daneshvar, D. H., Mez, J., Alosco, M. L., Kiernan, P. T., Sullivan, K., et al. (2023). Association of cumulative head impact force with chronic traumatic encephalopathy neuropathology in American football players. JAMA, 329(12), 1024–1034.

Daneshvar, D. H., Nowinski, C. J., McKee, A. C., & Cantu, R. C. (2023). Repetitive head impacts and chronic traumatic encephalopathy: Applying the Bradford Hill criteria for causation. Acta Neuropathologica, 145(4), 411–432.

McKee, A. C., Cairns, N. J., Dickson, D. W., Folkerth, R. D., Keene, C. D., Daneshvar, D. H., et al. (2021). The revised neuropathologic criteria for the diagnosis of chronic traumatic encephalopathy. Nature Communications, 12, 2291.

Kiernan, P. T., Montenigro, P. H., Daneshvar, D. H., et al. (2022). Age of first exposure to repetitive head impacts and risk of neurobehavioral symptoms in former American football players. Neurology, 98(17), e1765–e1773.

Solomon, G. S., Daneshvar, D. H., et al. (2024). Consensus recommendations on concussion prevention and long-term health outcomes in elite sport. British Journal of Sports Medicine, 58(9), 521–530.

Montenigro, P. H., Baugh, C. M., Daneshvar, D. H., et al. (2017). Clinical subtypes of chronic traumatic encephalopathy: Literature review and proposed research diagnostic criteria. Alzheimer’s Research & Therapy, 9(1), 56